| Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran AA Velayati, MR Masjedi, P Farnia, P Tabarsi, J Ghanavi, AH ZiaZarifi, ... Chest 136 (2), 420-425, 2009 | 896 | 2009 |
| Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance AL Manson, KA Cohen, T Abeel, CA Desjardins, DT Armstrong, ... Nature genetics 49 (3), 395-402, 2017 | 287 | 2017 |
| Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran MR Masjedi, P Farnia, S Sorooch, MV Pooramiri, SD Mansoori, AZ Zarifi, ... Clinical infectious diseases 43 (7), 841-847, 2006 | 229 | 2006 |
| Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level AA Velayati, P Farnia, MR Masjedi, TA Ibrahim, P Tabarsi, RZ Haroun, ... European Respiratory Journal 34 (5), 1202-1203, 2009 | 130 | 2009 |
| The NRAMPI, VDR and TNF-α gene polymorphisms in Iranian tuberculosis patients: the study on host susceptibility M Merza, P Farnia, S Anoosheh, M Varahram, M Kazampour, O Pajand, ... Brazilian Journal of Infectious Diseases 13, 252-256, 2009 | 125 | 2009 |
| The totally drug resistant tuberculosis (TDR-TB) AA Velayati, P Farnia, MR Masjedi International journal of clinical and experimental medicine 6 (4), 307, 2013 | 124 | 2013 |
| Differences in Cell Wall Thickness between Resistant and Nonresistant Strains of Mycobacterium tuberculosis: Using Transmission Electron Microscopy AA Velayati, P Farnia, TA Ibrahim, RZ Haroun, HO Kuan, J Ghanavi, ... Chemotherapy 55 (5), 303-307, 2009 | 115 | 2009 |
| First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran—eight years of surveillance M Shamaei, M Marjani, E Chitsaz, M Kazempour, M Esmaeili, P Farnia, ... International Journal of Infectious Diseases 13 (5), e236-e240, 2009 | 110 | 2009 |
| Anti-tuberculosis drug resistance and associated risk factors in a tertiary level TB center in Iran: a retrospective analysis MA Merza, P Farnia, P Tabarsi, M Khazampour, MR Masjedi, AA Velayati The Journal of Infection in Developing Countries 5 (07), 511-519, 2011 | 108 | 2011 |
| Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002–2006 MR Masjedi, P Tabarsi, E Chitsaz, P Baghaei, M Mirsaeidi, MV Amiri, ... The International Journal of Tuberculosis and Lung Disease 12 (7), 750-755, 2008 | 93 | 2008 |
| Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients P Farnia, MR Masjedi, M Mirsaeidi, F Mohammadi, V Vincent, M Bahadori, ... Journal of Infection 53 (5), 331-336, 2006 | 89 | 2006 |
| Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases P Baghaei, P Tabarsi, E Chitsaz, M Saleh, M Marjani, S Shemirani, ... American journal of therapeutics 17 (1), 17-22, 2010 | 87 | 2010 |
| Improving sensitivity of direct microscopy for detection of acid-fast bacilli in sputum: use of chitin in mucus digestion P Farnia, F Mohammadi, Z Zarifi, DJ Tabatabee, J Ganavi, K Ghazisaeedi, ... Journal of clinical microbiology 40 (2), 508-511, 2002 | 87 | 2002 |
| The recent-transmission of Mycobacterium tuberculosis strains among Iranian and Afghan relapse cases: a DNA-fingerprinting using RFLP and spoligotyping MR Masjedi, M Varahram, M Mirsaeidi, M Ahmadi, M Khazampour, ... BMC infectious diseases 8, 1-7, 2008 | 86 | 2008 |
| Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran P Baghaei, P Tabarsi, D Dorriz, M Marjani, M Shamaei, MV Pooramiri, ... American journal of therapeutics 18 (2), e29-e34, 2011 | 81 | 2011 |
| Geographic distribution of nontuberculous mycobacteria isolated from clinical specimens: a systematic review SMH Zweijpfenning, J van Ingen, W Hoefsloot Seminars in respiratory and critical care medicine 39 (03), 336-342, 2018 | 77 | 2018 |
| Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis—need for earlier identification of nontuberculosis mycobacteria P Tabarsi, P Baghaei, P Farnia, N Mansouri, E Chitsaz, F Sheikholeslam, ... The American journal of the medical sciences 337 (3), 182-184, 2009 | 75 | 2009 |
| Geographical distribution of cystic fibrosis; The past 70 years of data analyzis SB Mirtajani, P Farnia, M Hassanzad, J Ghanavi, P Farnia, AA Velayati Biomedical and Biotechnology Research Journal (BBRJ) 1 (2), 105-112, 2017 | 71 | 2017 |
| Evaluation of tuberculosis transmission in Tehran: using RFLP and spoloigotyping methods P Farnia, F Mohammadi, MR Masjedi, A Varnerot, AZ Zarifi, J Tabatabee, ... Journal of Infection 49 (2), 94-101, 2004 | 69 | 2004 |
| The NRAMP1, VDR, TNF-α, ICAM1, TLR2 and TLR4 gene polymorphisms in Iranian patients with pulmonary tuberculosis: A case–control study M Jafari, MR Nasiri, R Sanaei, S Anoosheh, P Farnia, A Sepanjnia, ... Infection, Genetics and Evolution 39, 92-98, 2016 | 67 | 2016 |
